Document is current
Any future updates will be listed below
-
Authors
Summerer, Isolde https://orcid.org/0009-0002-9144-010X
Walter, Wencke https://orcid.org/0000-0002-5083-9838
Meggendorfer, Manja https://orcid.org/0000-0002-9038-3265
Haferlach, Torsten https://orcid.org/0000-0003-0196-2837
Dicker, Frank
Hutter, Stephan
Nadarajah, Niroshan
Stengel, Anna https://orcid.org/0000-0003-3076-7723
Kuehn, Constanze
Kern, Wolfgang https://orcid.org/0000-0002-6452-2874
Bennett, John M.
Haferlach, Claudia https://orcid.org/0000-0002-6333-5049
Pohlkamp, Christian
- License Information
-
More Information
Article History
Received: 5 December 2024
Revised: 27 January 2025
Accepted: 21 February 2025
First Online: 3 March 2025
Competing interests
: CH, WK, and TH declare part ownership of Munich Leukemia Laboratory (MLL). IS, WW, MM, FD, SH, NN, AS, CK and CP are employed by the MLL.
: All patients gave their informed consent for genetic analyses and the use of laboratory results for research purposes. The study adhered to the tenets of the Declaration of Helsinki and was approved by the laboratory´s institutional review board and the Ethics Committee of the Bavarian Medical Association for the use of archived DNA/RNA samples and associated clinical information. The clinical data were retrieved, and the samples were collected and analyzed with the endorsement of the Ethics Committee of the Bavarian Medical Association.
